AAPL   320.32 (+0.69%)
FB   229.37 (+0.10%)
GOOGL   1,424.64 (+0.31%)
AMZN   2,419.93 (+0.40%)
NVDA   348.87 (+2.30%)
CGC   21.44 (+7.74%)
BABA   198.94 (-1.11%)
MU   47.90 (-3.13%)
GE   7.17 (-1.65%)
TSLA   818.07 (-0.26%)
ACB   16.63 (+8.69%)
F   5.92 (-1.82%)
GILD   76.04 (+1.52%)
DIS   118.78 (-2.26%)
NFLX   416.83 (-0.73%)
BAC   25.08 (-3.46%)
BA   155.10 (+3.73%)
AAPL   320.32 (+0.69%)
FB   229.37 (+0.10%)
GOOGL   1,424.64 (+0.31%)
AMZN   2,419.93 (+0.40%)
NVDA   348.87 (+2.30%)
CGC   21.44 (+7.74%)
BABA   198.94 (-1.11%)
MU   47.90 (-3.13%)
GE   7.17 (-1.65%)
TSLA   818.07 (-0.26%)
ACB   16.63 (+8.69%)
F   5.92 (-1.82%)
GILD   76.04 (+1.52%)
DIS   118.78 (-2.26%)
NFLX   416.83 (-0.73%)
BAC   25.08 (-3.46%)
BA   155.10 (+3.73%)
AAPL   320.32 (+0.69%)
FB   229.37 (+0.10%)
GOOGL   1,424.64 (+0.31%)
AMZN   2,419.93 (+0.40%)
NVDA   348.87 (+2.30%)
CGC   21.44 (+7.74%)
BABA   198.94 (-1.11%)
MU   47.90 (-3.13%)
GE   7.17 (-1.65%)
TSLA   818.07 (-0.26%)
ACB   16.63 (+8.69%)
F   5.92 (-1.82%)
GILD   76.04 (+1.52%)
DIS   118.78 (-2.26%)
NFLX   416.83 (-0.73%)
BAC   25.08 (-3.46%)
BA   155.10 (+3.73%)
AAPL   320.32 (+0.69%)
FB   229.37 (+0.10%)
GOOGL   1,424.64 (+0.31%)
AMZN   2,419.93 (+0.40%)
NVDA   348.87 (+2.30%)
CGC   21.44 (+7.74%)
BABA   198.94 (-1.11%)
MU   47.90 (-3.13%)
GE   7.17 (-1.65%)
TSLA   818.07 (-0.26%)
ACB   16.63 (+8.69%)
F   5.92 (-1.82%)
GILD   76.04 (+1.52%)
DIS   118.78 (-2.26%)
NFLX   416.83 (-0.73%)
BAC   25.08 (-3.46%)
BA   155.10 (+3.73%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Charles River Laboratories Intl.PPDIconExelixisPRA Health Sciences
SymbolNYSE:CRLNASDAQ:PPDNASDAQ:ICLRNASDAQ:EXELNASDAQ:PRAH
Price Information
Current Price$174.71$27.55$165.17$24.53$102.00
52 Week RangeBuyBuyHoldBuyHold
Beat the Market™ Rank
Overall Score1.32.11.71.81.4
Analysis Score2.43.52.23.42.2
Community Score2.34.02.62.62.6
Dividend Score0.00.00.00.00.0
Ownership Score1.01.02.01.01.0
Earnings & Valuation Score0.61.91.91.91.3
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyHold
Consensus Price Target$172.44$30.85$159.18$28.58$101.00
% Upside from Price Target-1.30% downside11.96% upside-3.63% downside16.52% upside-0.98% downside
Trade Information
Market Cap$8.48 billion$9.40 billion$8.99 billion$7.45 billion$6.27 billion
Beta1.14N/A0.861.541.09
Average Volume344,914658,808250,0963,455,399463,538
Sales & Book Value
Annual Revenue$2.62 billion$4.03 billion$2.81 billion$967.78 million$3.07 billion
Price / Sales3.302.383.167.772.12
Cashflow$11.09 per shareN/A$8.56 per share$1.09 per share$7.21 per share
Price / Cash15.76N/A19.3022.4414.14
Book Value$33.46 per shareN/A$28.23 per share$5.70 per share$17.38 per share
Price / Book5.225.854.305.87
Profitability
Net Income$252.02 millionN/A$373.99 million$321.01 million$243.02 million
EPS$6.73$0.98$6.88$1.02$4.80
Trailing P/E Ratio35.1528.1124.3326.3827.87
Forward P/E Ratio21.3129.6222.6331.0520.65
P/E Growth$1.79$4.37$2.55$1.48N/A
Net Margins9.09%N/A13.26%30.01%7.66%
Return on Equity (ROE)22.69%N/A24.20%18.01%27.59%
Return on Assets (ROA)7.47%N/A13.46%16.17%8.39%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.49%N/A0.05%N/A1.30%
Current Ratio1.75%N/A1.29%8.09%0.93%
Quick Ratio1.51%N/A1.29%7.98%0.93%
Ownership Information
Institutional Ownership Percentage92.89%65.46%82.71%79.99%98.27%
Insider Ownership Percentage1.90%N/A44.00%4.50%1.30%
Miscellaneous
Employees17,10023,00014,65048417,500
Shares Outstanding49.49 million348.58 million53.62 million306.66 million63.72 million
Next Earnings Date7/29/2020 (Estimated)8/5/2020 (Estimated)7/22/2020 (Estimated)7/29/2020 (Estimated)7/29/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.